APA (7th ed.) Citation

Attila Paszt, Aurel Ottlakan, Szabolcs Abraham, Zsolt Simonka, Marton Vas, Aniko Maraz, . . . Gyorgy Lazar. (2022). Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Attila Paszt, et al. Clinical Benefits of Oral Capecitabine over Intravenous 5-fluorouracyl Regimen in Case of Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Rectal Cancer. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Attila Paszt, et al. Clinical Benefits of Oral Capecitabine over Intravenous 5-fluorouracyl Regimen in Case of Neoadjuvant Chemoradiotherapy Followed by Surgery for Locally Advanced Rectal Cancer. Frontiers Media S.A., 2022.